Background. One-third of the world's population has latent infection with Mycobacterium tuberculosis, and 10%-15% of cases of reactivation occur at extrapulmonary sites without active pulmonary tuberculosis.
Mycobacterium tuberculosis (Mtb) can produce progressive disease or latent infection [1] . In areas of high endemicity, infection first occurs in childhood and in most cases is controlled. Only 10% of these primary infections lead to progressive disease [1, 2] . However, some bacilli remain in tissues in a nonreplicating dormant or slowly replicating stage for the rest of the individual's life. This latent form of tuberculosis (TB) is clinically asymptomatic. In countries with low or moderate endemicity, most active TB cases arise as a result of reactivation of latent bacilli [1, 2] . It is estimated that one-third of the world's population carries latent Mtb, and millions of cases of reactivated TB are predicted in the coming years [3, 4] .
One important point is the location of the bacilli during latent infection [1] . It has been assumed that latent bacilli are located in old fibrotic pulmonary granulomas, where the low nutrient supply and hypoxic microenvironment induce the low-level metabolism characteristic of latent bacilli [1] . However, we have detected mycobacterial DNA by conventional and in situ polymerase chain reaction (PCR) analysis in histologically normal lung tissue specimens from humans and mice during latent infection [5, 6] . This suggests that latent mycobacteria can reside not only in macrophages from old granulomas, but also in nonprofessional phagocytic cells from superficially normal tissue. However, recent results have shown mycobacterial DNA in apparently histologically normal adipose tissue from nontuberculous persons living in countries where TB is endemic (eg, Mexico) or nonendemic (eg, France), as well as in adipose tissue from mice with latent infection [7] . This is important because approximately 15% of cases of reactivation occur at extrapulmonary sites (ie, liver, spine, kidney, spleen, and brain) without active pulmonary TB [8, 9] . These findings suggest extrapulmonary reactivation rather than reactivation from pulmonary sites and subsequent migration of bacilli to other sites. The aims of this study were to determine whether Mtb DNA and RNA are present in extrapulmonary tissue specimens (from the liver, kidney, and spleen) from individuals who had no histopathologic findings specific for TB and died from causes other than TB and, if Mtb DNA and RNA are present, to identify their cellular locations. We confirmed our findings for humans in a murine model of chronic infection that is similar to latent infection.
METHODS

Human Samples
Forty-nine subjects who died from causes other than TB were included. The necropsy and tissue samples were collected at the Department of Pathology of the General Hospital of Mexico. Sex, age, and causes of death are presented in Table 1 . Subjects with human immunodeficiency virus infection or immunosuppressive treatment were excluded. Tissue samples were obtained during legally authorized autopsies with signed permission by a relative, who agreed to the donation of additional samples for the present study. The Ethics Committee of the General Hospital of México approved the study (code DI/ 11/310/03/083).
Between 4 and 6 hours after death, tissue samples were obtained from the lung, liver, spleen, and kidney. Samples were taken from random sites of all organs except lungs, in which samples were obtained from the base and apex. Samples were taken using sterile technique (ie, new scalpel blades, sterile clothes, and a flame) and divided into 2 fragments. One fragment was frozen in liquid nitrogen for DNA and RNA extraction and culture of Mtb in Middlebrook 7H9 broth (Difco Becton Dickinson, Sparks, MD), while the other fragment was fixed in 10% formaldehyde for histological analysis, acid-fast staining, and mycobacterial DNA detection by in situ PCR.
Detection of Mycobacterial DNA by Conventional and In Situ PCR
A fragment of each frozen sample was homogenized in a mini-bead beater (Biospec Products, Bartlesville, OK). DNA was extracted by the phenol-chloroform-isoamyl alcohol method [10] . Strict procedures and controls were followed to avoid cross-contamination between samples during DNA extraction. To detect mycobacterial DNA, conventional PCR for the specific insertion sequence IS6110 was carried out as previously described [11] . Considering that >90% of newborn infants in Mexico receive BCG vaccine, it was important to confirm that mycobacterial nucleic acids in positive samples were not derived from Mycobacterium bovis. We used conventional PCR to amplify the oxyR gene, highly specific for M. bovis, using primers JB21 (5′-TCGTCCGCTGATGCAAGTGC-3′) and JB22 (5′-CGTCCGCTGACCTCAAGAAG-3′) [12] . We used DNA from Mtb H37Rv and M. bovis BCG Danish 1331 as positive controls and DNA from Homo sapiens and Escherichia coli as negative controls. In negative samples, PCRs were carried out twice to confirm the result.
To increase the sensitivity of IS6110 detection, DNA hybridization was applied to all negative or weakly positive samples. In brief, Hybond N+ membrane was sensitized with denatured IS6110-PCR product from each necropsy, incubated for 2 hours with blocking reagent (Roche Applied Science, Indianapolis, IN), and incubated overnight with the IS6110-Biot probe. The membrane was washed with 2 × SSPE/0.5% sodium dodecyl sulfate and incubated with streptavidin-HRPO (Invitrogen, Camarillo, CA). Probe detection was performed with Immobilon Western Chemiluminescent HRP substrate (Millipore, Billerica, MA). The IS6110-Biot probe was made using the INS-1 primer 5′-CCTGCGAGCGTAGGCG TCGG-3′ labeled with biotin at the 5′ end, using as controls the DNA from H. sapiens, E. coli, and Haemophilus influenzae.
For in situ PCR detection of mycobacterial DNA, 5-μm sections from each paraffin block were examined, following the protocol previously described [5] [6] [7] . Lung sections from 1 TB case were used as positive control, and lung sections from a noninfected mouse were used as a negative control.
Spoligotyping
To determine whether the detected mycobacterial DNA was related to a particular genotype, as well as whether >1 genotype was in each necropsy specimen, spoligotyping was carried out for every positive sample, according to the manufacturer's recommendations (Ocimum Biosolution, Hyderabad, India). In all experiments, DNA from Mtb H37Rv and M. bovis BCG was used as a positive control. The reaction mixture was prepared with AmpliTaq Gold fast PCR Master Mix, (Applied Biosystems, Carlsbad, CA), using DRa 5′-GGTTTTGGGTCTGAC GAC-3′ biotinylated at the 5′ end and DRb 5′-CCGAGAGGGG ACGGAAAC-3′ primers and 1 µg of total DNA as a template. Spoligotypes in octal code were compared with the SPOLDB4.0 database of the Pasteur Institute of Guadeloupe (available at: http://www.pasteur-guadeloupe.fr/tb/bd_myco.html).
Quantification by Real-Time PCR of Mycobacterial Gene Expression
To define bacterial viability in tissue samples in which we detected mycobacterial DNA, we used a previously described technique with some modification to determine mycobacterial gene expression by real-time PCR after isolation of putative mycobacterial RNA [13, 14] . Ten samples from different subjects that showed the strongest PCR positivity for IS6110 were selected. The tissue was homogenized using a Multi-Gen 7 mm generator and centrifuged; the supernatant contained eukaryotic RNA, while the pelleted material contained the bacilli. To isolate the bacterial RNA, the pellets suspended in TRIzol (Gibco BRL, Camarillo, CA) were disrupted using a Mini-Bead Beater-8 (Biospec Products, Bartlesville, OK) and zirconia and silica beads. After vortexing and centrifugation, the supernatant contained Mtb RNA. Bacterial RNA was isolated using 4 cycles of purification with an RNeasy column (Qiagen, Valencia, CA), followed by DNase incubation. We used mycobacterial 16S ribosomal RNA (rRNA) for reference constitutive gene expression and as a viability marker because this gene is expressed in all growth conditions [13] . Primers for 16S rRNA, isocitrate lyase (icl), and α-crystallin (acr) mycobacterial genes were designed with Primer Express software, version 2.0 (Applied Biosystems, Carlsbad, CA). The nucleotide sequences of the forward and reverse primers were as follows: for 16S rRNA, 5′-TCCCGGGCCTTGTACACA-3′ (forward) and 5′-CCACTGGCTTCGGGTGTAA-3′ (reverse); for icl, 5′-ACACCTACCCCGACCAGAG-3′ (forward) and 5′-TG CAGCTCGTAGACGTTGAG-3′ (reverse); and for acr, 5′-CGAGAAGGACGTCGACATTA-3′ (forward) and 5′-CC TTGTCGTAGGTGGCCTTA-3′ (reverse). The quality and quantity of RNA were evaluated by spectrophotometry and electrophoresis. Complementary DNA (cDNA) synthesis was Figure 1 . Detection of mycobacterial DNA in lung and liver samples by conventional polymerase chain reaction (PCR) plus DNA hybridization. To increase the sensitivity of IS6110 detection, DNA hybridization was applied to all negative (box) or weakly positive samples by conventional and in situ PCR. Hybridization was performed in duplicate, using the PCR product; the number corresponds to the patient referred in 
Murine Model of Latent Infection
To evaluate the presence of extrapulmonary Mtb in apparently histologically normal tissues, we used a murine model of chronic infection that is similar to latent infection [6] . Hybrid F1 C57BL/DBA mice were infected intratracheally with 1 × 10 3 live Mtb H37Rv. Groups of 5 mice were sacrificed at days 30, 90, 150, and 210 after infection. The kidney, spleen, and liver were collected, and fragments were prepared as described above for histological analysis and IS6110 detection. Serial sections were stained with Ziehl-Neelsen. Another tissue fragment was used for quantification of colony-forming units (CFUs) [6] .
RESULTS
Mycobacterial DNA in Pulmonary and Extrapulmonary Tissues
A total of 43 necropsy specimens (from 19 of 23 males and 24 of 26 females) were positive for mycobacterial DNA (Table 1) . We considered necropsy specimens as positive when IS6110 was detected in at least 1 tissue by conventional PCR, PCR plus DNA hybridization, or in situ PCR. As expected, the lung was the organ that most commonly yielded specimens positive for IS6110 (in 36 cases), but spleen specimens (from 35), kidney specimens (from 34), and liver specimens (from 33) were also positive (Table 1 ). In 35 subjects (70%), we found mycobacterial DNA in lung and extrapulmonary tissues, but in 7 (14%), detection was exclusively in extrapulmonary tissues. When the result was difficult to interpret, we performed PCR plus DNA hybridization ( Figure 1 ). Thus, 34 of 141 samples (3 lung specimens, 13 liver specimens, 16 spleen specimens, and 2 kidney specimens) that were negative by conventional PCR yielded positive results after hybridization. No samples were positive for M. bovis. By use of in situ PCR, we detected mycobacterial DNA in endothelial cells, type II pneumocytes, and alveolar macrophages (data not shown), which corroborates previous findings for lung tissue [5] . In kidney, positivity was localized in the parietal cells of Bowman's capsule and, on occasion, in epithelial cells from convoluted proximal tubules (Figure 2 ). In spleen, IS6110 positivity was found in red pulp macrophages and sinusoidal endothelial cells, while in liver, positivity was located in Kupffer cells and sinusoidal endothelium. On occasion, hepatocytes and portal biliary duct epithelial cells were also positive (Figure 2) . None of these positive tissues showed any apparent histological abnormality, such as granulomas, inflammatory infiltrates, or fibrosis.
Spoligotyping
In 54 positive tissue specimens from pulmonary and extrapulmonary sites of 30 subjects, we found 42 different genotypes, but only 8 genotypes had a match in the SPOLDB4.0 database. The most frequently detected genotype (in 7 samples from 6 subjects) corresponded to shared international type (SIT) 53. This profile has been reported 2380 times in the SITVIT database (54 of which were reported from Mexico). Other profiles found were SIT 523 (in 3 samples), SIT 291 (in 2), and SITs 245, 521, 1166, 1196, and 1690 (in 1 each). With the exception of SIT 53, none of the profiles found was previously reported in Mexico. We found 34 orphan types from different organs. They had spoligotyping codes, but the codes did not have matches in the database (Table 2) 
Detection of Mycobacterial Gene Transcription by Real-Time PCR
To confirm the viability of mycobacteria, we selected 10 tissue samples (4 from lungs, 4 from kidneys, and 2 from spleens) with the highest positivity to IS6110 detection by PCR. Spleen taken from chronically infected mice was the positive control. We selected the mycobacterial 16S rRNA as a viability marker, and for latency we selected α-crystallin (encoded by acr), since this protein is expressed during stressful conditions [14] , and isocitrate lyase (encoded by icl), because Mtb uses this enzyme in the metabolism of fatty acids during chronic infection [13] .
In the 10 selected samples, we detected 16S rRNA ( Figure 3A ), while icl was detected in 8 samples (4 from kidneys, 3 from lungs, and 1 from spleen) at levels varying from 1 × 10 1 to 1 × 10 6 copies per 10 6 copies of 16S RNA ( Figure 3 ). In 4 samples that were positive for icl, we also detected acr (in 2 kidney specimens, 1 lung specimen, and 1 spleen specimen). The expression of acr was higher in all cases (range, 1 × 10 7 -1 × 10 9 copies).
Murine Model
We used a mouse model that mimics latency, with a low, stable lung bacillary load without weight loss, spontaneous reactivation, or death [6] . Low and stable numbers of CFUs were detected only in liver and spleen ( Figure 4) . After histological analysis, acid-fast staining showed bacilli in tissue sections from liver and spleen, specifically in macrophages, hepatocytes, and endothelial cells from apparently normal tissue ( Figure 4 ). In situ PCR showed positivity in the same cells as in the human tissues, but the labeling was stronger, and the cellular distribution was much wider (Figure 4) .
DISCUSSION
Previous work has demonstrated the presence of mycobacterial DNA in macroscopically and histologically normal lung and adipose tissue from people who died from causes other than TB, suggesting latent infection [5, 7] . Here, we confirm and extend these observations by demonstrating the presence of mycobacterial DNA in pulmonary and multiple extrapulmonary tissues from people who died from causes other than TB and had no history of this disease. This agrees with many reports in which Mtb DNA was detected in extrapulmonary samples from patients in a wide range of geographical locations who were putatively without illness [15] [16] [17] [18] [19] .
We found a higher percentage of pulmonary and extrapulmonary specimens positive for mycobacterial DNA than in our previous study [5] . This difference can be explained by the use of DNA hybridization in addition to PCR, which greatly increased sensitivity. We detected mycobacterial DNA in both pulmonary and extrapulmonary sites in 84% of the studied cases and exclusively in extrapulmonary sites in 14%. The organ that was most commonly positive was the lung (72%), but the frequency of positive findings was similarly high for the spleen (70%), the kidney (68%), and the liver (66%). All of these organs have high blood throughput, which facilitates infection. Similarly the in situ PCR study showed mycobacterial DNA preferentially in Kupffer cells and red pulp macrophages. Thus, Mtb may be phagocytosed during hematogenous dissemination by cells from the mononuclear phagocytic system, as well as by nonprofessional phagocytic cells, such as endothelial cells, which also frequently showed IS6110 positivity. Endothelial cells are easily infected by Mtb in vitro, and recent microarray studies showed an extensive shutdown of diverse bacterial genes related to metabolic pathways, which suggests bacillary dormancy, or at least greatly reduced activity [20] .
Kidney samples commonly showed mycobacterial DNA. In situ PCR revealed positivity in epithelial cells, particularly Bowman's parietal cells. Renal glomeruli filter a high volume of blood, and the parietal Bowman's epithelium is exposed to the glomerular filtrate. This suggests that, despite their size, mycobacteria can pass through capillary walls and infect epithelial cells from glomeruli and proximal tubules. At present, we have no insights into how this might occur or whether they are transported within cells. Interestingly, there were no histological abnormalities in any of these extrapulmonary tissues, as previously reported for the lung [5] . Since all these positive cells are heavily exposed to circulating blood, hypoxia might not be a significant factor in the induction of bacterial dormancy. Nitric oxide could be important in these cellular settings. Nitric oxide is produced by endothelial cells and macrophages, and treatment with nitric oxide-blocker drugs in animal models provokes mycobacterial reactivation [21] .
Because extrapulmonary TB occurs commonly in lymph nodes, genitourinary tract, meninges, and pericardium, it will be important to extend these studies to material from these sites. We do not know whether reactivation in these other sites is local or due to spread from sites such as those we have studied.
The use of PCR-based genotyping methods such as spoligotyping to differentiate Mtb strains has revealed multiple strains within single patients in several geographical areas [22] [23] [24] . These studies have been performed in patients with active infection. Our spoligotyping study showed 42 different genotypes from 30 individuals, including 34 orphan strains. This variability suggests chronic sporadic infection. Interestingly, 50% of the studied individuals showed only 1 genotype, while the other 50% showed 2 or 3 genotypes. Thus, mixed infection is a common condition in latency, and latent infection with 1 strain does not elicit protection from infection with another strain. Moreover, our genotyping studies showed that all the positive cases corresponded to Mtb infection. No samples were positive for M. bovis, which is important considering that BCG vaccination is a prevalent in Mexico.
Detection of mycobacterial DNA does not mean that the organisms are alive. Several studies have focused on understanding the quorum-sensing signals used by Mtb for resuscitation from the nonculturable state. During active growth, Mtb organisms secrete resuscitation-promoting factor (Rpf ), which is required for growth of in vitro-induced vegetative cells and for resuscitation of dormant cells [25, 26] . Latent Mtb has extremely low metabolic activity and needs Rpf and special requirements to promote resuscitation. However, no strains could be recovered from autopsy specimens cultured with Rpf according the conditions described by Mukamolova et al (data not shown). Therefore, we used a recently reported technique for isolating mycobacterial RNA from infected tissues [26] [27] [28] . Ten samples were studied, and all showed expression of the constitutive mycobacterial gene encoding Table 1 ) according their high positivity to IS6110, as determined by conventional PCR. A, Transcription of 16S ribosomal RNA (rRNA) as a viability marker. B, Expression of 2 related latency genes, acr (which encodes alpha-crystallin) and icl (which encodes isocitrate lyase). The messenger RNA (mRNA) copy numbers for acr and icl are given relative to 1 million copies of 16S RNA.
ribosomal 16S, suggesting that organisms were viable in a nonculturable state [26, 29] . We extended this study by determining the expression of factors associated with dormancy, such as acr and icl [30, 31] . acr is a prominent stationary phase-induced protein produced by mycobacteria in humans during infection [1, 32] . It is upregulated in vitro after exposure of Mtb to hypoxia or nitric oxide precursors and during treatment [14, 33] . We detected acr expression in 4 samples, but the high copy numbers suggest that bacilli were stressed. Biochemical studies indicate that, in chronically infected lung tissue, fatty acids are a major carbon source for Mtb [34] . In Mtb strain H37Rv (but not in nonvirulent strains), icl activity has been reported to increase in proportion to the age of the culture. Fatty acids are available within the macrophage phagosome, and Mtb might use these as a carbon source [31] . Thus, icl promotes persistence by enhancing bacterial survival within inflammatory macrophages [35] . We detected some expression of icl in 8 of 10 tissue samples.
By use of a murine model of chronic infection similar to latent infection, we confirmed the data found in the human necropsy specimens. In contrast with latent infection in humans, in the murine model the bacilli were not in a truly dormant state because they grew in culture. However, hematogenous dissemination of bacilli and infection of nonprofessional phagocytic cells in superficially normal tissue was seen. Acid fast bacilli were detected in splenic macrophages and in hepatocytes, and the cellular location of mycobacterial DNA in murine tissues was the same as in human tissue. A major concern in this study is the possibility of contamination, especially as the conditions in the autopsy room were not ideal. We conducted tissue sample collection and the associated techniques with strict procedures to avoid contamination (Table 3) . We emphasize in particular the following 2 facts. First, contamination from other activities in the laboratory would yield spoligotypes characteristic of BCG and of H37Rv, but these were not found. Second, in situ PCR showed DNA in professional and nonprofessional phagocytes, whereas contamination would give a random distribution. These and other points are highlighted in Table 3 . Thus, we believe that the results are reliable.
In conclusion, we have confirmed the often forgotten classical studies by Opie and Aronson, who demonstrated in guinea pigs in 1927 that latent Mtb survives in histologically normal tissue, not in old granulomas [36] . Moreover, we have shown that the bacteria persist in extrapulmonary tissues almost as frequently as in lung and that they are located within cells with limited antigen-presentation abilities, such as epithelial cells. This may be of great advantage for the tubercle bacillus and can explain the lack of local histological reaction. The frequent presence of bacteria in endothelial cells in various organs suggests that hematogenous dissemination of free Mtb occurs during the infection process.
Another important finding is that there can be latent infection with >1 strain of Mtb in the same individual. Therefore, latent infection with one strain does not elicit protection from infection with another strain. Moreover the bacterial strains in different individuals were of different genotypes, indicating that the ability to disseminate and establish latent infection in multiple organs is a fundamental strategy used by Mtb for survival and not an unusual property of a particular strain. Clearly, there is more to Mtb infection than phagocytosis by macrophages, survival in these cells, and granuloma formation. Standardized phenol/chloroform DNA extraction [5] DNA from each sample was extracted on different days, using new sterile material and molecular biology grade chemicals. To avoid cross-contamination, samples were manipulated under biosafety level II cabinets until the alcohol precipitation step, which was performed in a laboratory where mycobacterial DNA had never been isolated. DNA from tissues, bacteria, and the cell line used as negative controls was extracted under the same conditions. IS6110 amplification [6] DNA from M. tuberculosis complex was detected by a highly specific PCR method based on direct amplification of insertion sequence IS6110 (1 to >25 copies in genome). IS6110-PCR is a highly specific method for detection of M. tuberculosis, with the ability to detect 1 fg of H37Rv DNA (corresponding to 1 genome).
The sensitivity of the method has been reported to be 100% for smear-positive clinical samples and at least 59% for smear-negative and extrapulmonary clinical samples. All of our negative controls (human DNA and DNA from other nonrelated organisms) were negative by IS6110 PCR. M. bovis infection was discounted by PCR amplification of the oxyR gene, which is specific for M. bovis and attenuated BCG vaccine substrains [12] .
IS6110-Hybridization
Sequence-specific hybridization of IS6110 with a PCR-generated single-strand probe increases the threshold of detection and might reduce false-negative results (ie, weakly positive and negative samples) obtained by IS6110 PCR. High-stringency conditions decrease the chance of nonspecific binding of the probe to human DNA; to bacterial DNA, such as that from E. coli and H. influenzae; or to the oligonucleotides used for IS6110 PCR.
In situ IS6110-PCR This has a lower sensitivity than conventional IS6110 PCR, but the intracellular localization of the DNA signal as small dots in professional and nonprofessional phagocytes in positive samples with correct positive and negative controls directly disproves cross-contamination, which would yield a random distribution of the DNA signals.
Spoligotyping This is a genotyping method used for simultaneous detection and typing of M. tuberculosis complex bacteria. The obtained SITs did not correspond to spoligotype patterns of the commonly used laboratory reference strain, M. tuberculosis H37Rv, or the common vaccine strain, M. bovis BCG. Human DNA did not show any band.
Abbreviations: E. coli, Escherichia coli; H. influenzae; Haemophilus influenzae; M. bovis, Mycobacterium bovis; M. tuberculosis, Mycobacterium tuberculosis; PCR, polymerase chain reaction; SIT, shared international type.
